BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 21073405)

  • 21. [Piper methysticum (kava) under discussion: observations on quality, effectiveness and safety].
    Schmidt M; Nahrstedt A; Lüpke NP
    Wien Med Wochenschr; 2002; 152(15-16):382-8. PubMed ID: 12244883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-the-counter psychotropics: a review of melatonin, St John's wort, valerian, and kava-kava.
    Heiligenstein E; Guenther G
    J Am Coll Health; 1998 May; 46(6):271-6. PubMed ID: 9609974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U; Kieser M
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herbal medicines in Hawaii from tradition to convention.
    Norton SA
    Hawaii Med J; 1998 Jan; 57(1):382-6. PubMed ID: 9509742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of the safety of kava extract in the treatment of anxiety.
    Stevinson C; Huntley A; Ernst E
    Drug Saf; 2002; 25(4):251-61. PubMed ID: 11994028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kava treatment in patients with anxiety.
    Geier FP; Konstantinowicz T
    Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herbal remedies for anxiety - a systematic review of controlled clinical trials.
    Ernst E
    Phytomedicine; 2006 Feb; 13(3):205-8. PubMed ID: 16428031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kava: an herbal sedative.
    Kinder C; Cupp MJ
    Nurse Pract; 1998 Jun; 23(6):14, 156. PubMed ID: 9656257
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of kava (Piper methysticum) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial.
    Cribb L; Sarris J; Savage KM; Byrne GJ; Metri NJ; Scholey A; Stough C; Bousman CA
    Phytother Res; 2023 Dec; 37(12):5897-5903. PubMed ID: 37767766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.
    Sarris J; Scholey A; Schweitzer I; Bousman C; Laporte E; Ng C; Murray G; Stough C
    Hum Psychopharmacol; 2012 May; 27(3):262-9. PubMed ID: 22311378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiolytic-like effects of kava-kava in the elevated plus maze test--a comparison with diazepam.
    Rex A; Morgenstern E; Fink H
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):855-60. PubMed ID: 12369257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is kava extract effective for treating anxiety?
    Abadi S; Papoushek C; Evans MF
    Can Fam Physician; 2001 Sep; 47():1745-7. PubMed ID: 11570299
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kava (Piper methysticum).
    Cassileth B
    Oncology (Williston Park); 2011 Apr; 25(4):384-5. PubMed ID: 21618963
    [No Abstract]   [Full Text] [Related]  

  • 35. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.
    Sarris J; McIntyre E; Camfield DA
    CNS Drugs; 2013 Apr; 27(4):301-19. PubMed ID: 23653088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.
    Sarris J; Stough C; Teschke R; Wahid ZT; Bousman CA; Murray G; Savage KM; Mouatt P; Ng C; Schweitzer I
    Phytother Res; 2013 Nov; 27(11):1723-8. PubMed ID: 23348842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
    Pittler MH; Ernst E
    J Clin Psychopharmacol; 2000 Feb; 20(1):84-9. PubMed ID: 10653213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian.
    Weeks BS
    Med Sci Monit; 2009 Nov; 15(11):RA256-62. PubMed ID: 19865069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed-type hypersensitivity reaction to kava-kava extract.
    Schmidt P; Boehncke WH
    Contact Dermatitis; 2000 Jun; 42(6):363-4. PubMed ID: 10871112
    [No Abstract]   [Full Text] [Related]  

  • 40. Kava (Piper methysticum) Extract for the Treatment of Nervous Anxiety, Tension and Restlessness.
    Kuchta K; Hladikova M; Thomsen M; Nahrstedt A; Schmidt M
    Drug Res (Stuttg); 2021 Feb; 71(2):83-93. PubMed ID: 33207379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.